In Brief: Antacid meeting
This article was originally published in The Tan Sheet
Executive Summary
Antacid meeting: FDA to meet with the Nonprescription Drug Manufacturers Association on Aug. 10 to discuss OTC antacids. A broad range of issues is expected to be covered at the "OTC feedback" meeting, including antacid ingredients, labeling changes, maximum daily dosing and consumer-use data...